1204 PHARMACOKINETICS OF MIRAVIRSEN, A MIR-122 INHIBITOR, PREDICT THE PROLONGED VIRAL LOAD REDUCTION IN TREATMENT NAIVE GENOTYPE 1 HCV INFECTED PATIENTS

Authors:
  • RPR. Persson
    R. Persson
  • MHM. Hodges
    M. Hodges
  • BKB.D. King
    B.D. King
  • ACA. Chen
    A. Chen
  • KZK. Zeh
    K. Zeh
  • ALA.A. Levine
    A.A. Levine

Abstract
No abstract available